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Abstract
The opportunistic pathogen Pseudomonas aeruginosa can cause severe infections in patients suffering from disruption or
disorder of the skin barrier as in burns, chronic wounds, and after surgery. On healthy skin P. aeruginosa causes rarely
infections. To gain insight into the interaction of the ubiquitous bacterium P. aeruginosa and healthy human skin, the
induction of the antimicrobial protein psoriasin by P. aeruginosa grown on an ex vivo skin model was analyzed. We show
that presence of the P. aeruginosa derived biosurfactant rhamnolipid was indispensable for flagellin-induced psoriasin
expression in human skin, contrary to in vitro conditions. The importance of the bacterial virulence factor flagellin as the
major inducing factor of psoriasin expression in skin was demonstrated by use of a flagellin-deficient mutant. Rhamnolipid
mediated shuttle across the outer skin barrier was not restricted to flagellin since rhamnolipids enable psoriasin expression
by the cytokines IL-17 and IL-22 after topical application on human skin. Rhamnolipid production was detected for several
clinical strains and the formation of vesicles was observed under skin physiological conditions. In conclusion we
demonstrate herein that rhamnolipids enable the induction of the antimicrobial protein psoriasin by flagellin in human skin
without direct contact of bacteria and responding cells. Hereby, human skin might control the microflora to prevent
colonization of unwanted microbes in the earliest steps before potential pathogens can develop strategies to subvert the
immune response.
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Introduction
Our skin is constantly challenged by microbes but is rarely
infected. On intact skin bacterial growth is controlled by the
combined action of complementary systems. At the outermost
border, the stratum corneum layer, a lipid-rich matrix with embedded
corneocytes, constitutes a physical barrier with a protective surface
pH, nutrient limitation, and physical removal from body surfaces
by desquamation. Bacteriostatic and bactericidal compounds such
as antimicrobial proteins (AMPs) provided by a keratinocyte
derived ‘‘biochemical barrier’’ support this protective function at
the skin surface. Once this barrier is disturbed, bacteria or
bacterial factors have access to living epidermal keratinocytes and
can provoke a host defense program. Irrespectively of manipulat-
ing strategies of various bacteria to escape from immune response,
finally the sum of effectiveness of the host responses determines if a
bacteria is commensal or pathogen.
AMPs are of major importance in maintaining an intact skin
barrier against potentially invading microorganisms and in
balancing the natural commensal flora on skin. AMPs of the skin,
such as the human b-defensins (hBD)-1-3, RNase7, the cathe-
licidin LL-37, and psoriasin (S100A7c) comprise a heterogeneous
group of molecules that use different mechanisms to kill
microorganism [1–3]. Studies in mouse models with deficiencies
in some AMP genes underline the importance of these molecules
in protecting the host epithelia against bacterial infections [4–6].
One of the dominating AMP of healthy human skin is the S100
protein psoriasin [7] that shows antimicrobial activity in vitro
preferentially against E. coli and other Gram negative bacteria [8].
The physiological role of psoriasin protecting the skin against E.
coli colonization and infection was underlined by in vivo
experiments using neutralizing antibodies. Subsequent studies in
cultured human keratinocytes identified the Toll-like receptor
(TLR)-5 ligand flagellin as ‘‘pathogen-associated molecular
pattern’’ (PAMP) of E. coli, responsible for the expression of
psoriasin mRNA and protein [9].
Although not belonging to the typical resident skin microflora,
P. aeruginosa, a soil and water-born Gram-negative bacterium is
commonly found at different locations of healthy individuals [10].
Here it is usually not infecting healthy skin. In patients suffering
from burns, chronic wounds, surgery, and injuries associated with
a disruption or disorder of the barrier function of the skin,
however, P. aeruginosa is able to cause severe infections. The
flexible, non-stringent metabolic requirements enable P. aeruginosa
to occupy a diversity of ecological niches, and in combination with
the high resistance to a large number of disinfectants and
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negative bacterium associated with nosocomial infections [11].
To sustain unfavorable conditions, survival of P. aeruginosa at
surfaces is often interconnected with a switch from the motile
planktonic way of life to a structured community of bacterial cells
enclosed in a self-produced polymeric matrix. Rhamnolipids,
biosurfactants produced by P. aeruginosa, play an important role in
the initial phase of this biofilm formation [12] by maintaining
channels in the biofilm as well as in the dispersal of cells from the
biofilm [13]. Additionally, rhamnolipids display excellent antimi-
crobial activity against a wide variety of Gram-positive and Gram-
negative bacteria as well as fungal species [14,15] and therefore
might support P. aeruginosa in competition for new habitats.
Rhamnolipids are composed of mono- or di-rhamnose linked to
3-hydroxy-fatty acids of different length, produced during
stationary phase of growth. On the genetic level the biosynthesis
of rhamnolipids in P. aeruginosa is dependent on the rhlAB operon,
controlled by quorum sensing [16]. Rhamnolipids can be
expressed in a concerted manner with different factors and are
considered to be important virulence factors [17]. Due to their
amphiphilic character, rhamnolipids particularly enhance the
biodegradation of hydrophobic compounds such as lipids by
solubilization within micelles, thereby increasing the solubility in
aqueous media and finally promoting the uptake by the bacterium
[18]. Depending on the intended use, P. aeruginosa can produce
about 30 different congeners of rhamnolipids to meet the required
physico-chemical properties [19]. In addition, rhamnolipids are
able to modulate the outer leaflet of P. aeruginosa mainly by
removing lipopolysaccharide [20], which results in increasing
hydrophobicity [21], thereby minimizing the distance to poten-
tially hydrophobic substrates/surfaces, for instance the stratum
corneum. Recently, we could demonstrate that rhamnolipids can
shed the PAMP flagellin, the main constituent of the flagellum
[22]. A single polar flagellum provides P. aeruginosa motility and
allows chemotaxis. Especially in airway epithelia the role of
flagellin in the pathogenesis of respiratory tract infections is well
investigated [23,24]. Thereby, activation of the host’s innate
immune system is generally mediated by interaction of flagellin
and the extracellular TLR-5 [25].
Combining the previous findings that P. aeruginosa can utilize
hydrophobic substances which might be lipids of the skin with the
aid of rhamnolipids [18], the rhamnolipid mediated shedding of
flagellin [22], and the flagellin mediated induction of the
antimicrobial peptide psoriasin [9], we aimed to analyze the effect
of flagellin-induced psoriasin expression in an ex vivo skin model
and the contribution of rhamnolipids in this process.
Results
P. aeruginosa flagellin induces psoriasin release in
primary keratinocytes
In order to demonstrate that P. aeruginosa derived flagellin is
capable of inducing psoriasin and IL-8 in human keratinocytes as
described for E. coli derived flagellin [9] cultured keratinocytes
were stimulated with HPLC-purified flagellin. ELISA-analyses of
stimulated keratinocyte supernatants revealed a dose-dependent
psoriasin- and IL-8-release that was significantly induced by
flagellin at concentrations $1 ng/ml (Fig. 1).
Flagellin-deficient P. aeruginosa does not induce
psoriasin in human skin ex vivo
Beside flagellin, P. aeruginosa might produce other virulence
factors during adaptation to certain environmental cues, leading to
the induction of psoriasin. To further confirm the role of flagellin
as the principal inducer of psoriasin in vivo, wildtype flagellated P.
aeruginosa (PAK) and its flagellin-deficient mutant strain (DfliC)
were cultivated on ex vivo skin explants. Both strains were separated
from explants by transwells to omit the direct contact between
pathogen and skin. Both strains reached similar optical densities at
the end of incubation (data not shown). Immunohistochemical
analyses revealed an evenly distributed, strong increase of
psoriasin expression in the suprabasal epidermal layers of ex vivo
skin biopsies co-cultivated with the P. aeruginosa wildtype strain
(Fig. 2a). In contrast, the flagellin mutant DfliC did not induce
psoriasin expression in the skin (Fig. 2a). Similar immunohisto-
chemical analyses were obtained when skin biopsies were directly
treated with P. aeruginosa or its flagellin-deficient mutant (data not
shown). To verify the presence of flagellin under these conditions,
bacterial-free culture supernatants were analyzed. As shown in
Fig. 2b, Western blot analyses with an anti-FliC antibody revealed
the presence of flagellin only in supernatants obtained from the
wildtype PAK strain. Based on our hypothesis that rhamnolipids
might contribute to the flagellin-induced psoriasin expression in
skin, biopsies directly treated with P. aeruginosa wildtype or DfliC
mutant were analyzed for the presence of the P. aeruginosa derived
rhamnolipids by qualitative mRNA expression of the rhlA gene, a
Figure 1. Dose-dependent effect of P. aeruginosa flagellin on
psoriasin and IL-8 expression. Keratinocytes were stimulated with
the indicated concentrations of flagellin for 24 h. Subsequently,
psoriasin and IL-8 concentrations of the supernatants were measured
by ELISA. Data are means 6 SD (n=3). Stimulation with flagellin
increase psoriasin and IL-8 release significantly. * P,0.05 compared to
unstimulated cells (unpaired student’s t-test).
doi:10.1371/journal.pone.0016433.g001
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could be detected for PAK as well as for DfliC.
Rhamnolipids are needed for a flagellin-induced
psoriasin expression in human skin ex vivo
In contrast to cultivated keratinocytes, the skin possesses a first,
physical barrier with the lipid-rich stratum corneum preventing the
subjacent cells from damage. Ex vivo treatment of skin explants
with excess of purified P. aeruginosa flagellin (700 ng/ml) and
subsequent immunohistochemical analyses showed no expression
of psoriasin in the epidermis (Fig. 3).
Considering our observation that P. aeruginosa produces
rhamnolipids during growth on the skin’s surface, the effect of
rhamnolipids in combination with flagellin was examined in the ex
vivo model. Immunohistochemical analyses of psoriasin expression
in full thickness skin biopsies revealed a strong increase of psoriasin
immunoreactivity in the upper epidermis only when flagellin was
applied together with rhamnolipids (Fig. 3). This staining pattern
was comparable to that found for skin biopsies co-incubated with
PAK wildtype strain (Fig. 2a). Application of rhamnolipids alone
did not induce psoriasin expression (Fig. 3).
Production of rhamnolipids by clinical P. aeruginosa
isolates
To survey whether the flagellin release by rhamnolipids is
restricted to laboratory strains, the flagellin and rhamnolipid
expression of several clinical P. aeruginosa isolates from different
sources were analyzed. All of the tested clinical P. aeruginosa strains
were capable of swimming, indicating an intact flagellum.
According to the biochemical approach, tested P. aeruginosa strains
produced rhamnolipids at concentrations above the critical micelle
concentration (CMC) of ,20 mg/ml, determined for Rha-C10-
C10, Rha-Rha-C10-C10 [26]. The obtained values vary between
20 mg/ml and 795 mg/ml (Table 1). Since the CMC is dependent
on composition of different rhamnolipids [19], electrospray-
ionization-mass-spectrometry (ESI-MS) in the negative ionization
modus was performed to identify rhamnolipid composition.
Figure 4 shows a typical ESI-MS spectrum of the rhamnolipid
preparations of the tested clinical P. aeruginosa isolates. Prominent
ion signals were detected at m/z 503 and 649 and fit well with the
MH
- of the rhamnolipids Rha-C10-C10 (calculated mass: 504 Da)
and Rha-Rha-C10-C10 (calculated mass: 650 Da). The obtained
fragmentation ions of subsequent tandem mass spectrometry
analyses confirmed the presence of two major rhamnolipids
(Fig. 4).
Effect of acetone and different detergents on the
flagellin-induced psoriasin expression
To investigate the mechanism of the rhamnolipid mediated
psoriasin response to flagellin in the ex vivo model, the effect on the
epidermal skin barrier was analyzed. As it is known that psoriasin
secretion is enhanced after experimental skin barrier disruption
[27] the ex vivo skin barrier was disturbed by acetone treatment. As
shown in Figure 5, acetone treatment itself was sufficient to elicit
psoriasin expression in the used model. Stimulation of acetone-
treated skin with flagellin resulted in a similar psoriasin expression
in the immunohistochemical analyses (Fig. 5).
Rhamnolipids are anionic amphiphilic molecules with detergent
properties. Therefore chemically synthesized detergents were
analyzed to function as substitute of rhamnolipids in the flagellin
delivery across the upper skin layers. The anionic detergent
deoxycholate (DOC), the zwitterionic 3-[(3-Cholamidopropyl)di-
methylammonio]-1-propanesulfonate hydrate (CHAPS), the cat-
ionic hexadecyltrimethyl ammonium bromide (CTAB), and the
nonionic TWEEN 20 were applied above their CMC on ex vivo
skin explants in the absence or presence of flagellin. Subsequently,
immunohistochemical analyses of psoriasin expression were
performed. As shown in Figure 5, all detergents by their own
Figure 2. Flagellin is delivered to apical epithelial cells across the stratum corneum and induces psoriasin expression. A:
Immunohistochemical analyses of psoriasin expression (Vector red) in full-thickness ex vivo skin explants. One representative experiment is shown
(n=3–6). Biopsies were incubated with P. aeruginosa wildtype (PAK) and its flagellin deletion mutant (DfliC) in transwells for 24 h. B: Flagellin Western
Blot analysis of the correspondent culture supernatants. C: Rhamnolipid expression of P. aeruginosa grown directly on ex vivo skin was assessed by
rhlA mRNA expression. A representative gel out of three independent experiments is shown with a 100 bp ladder (lane1), reverse transcription PCR
products of PAK (lane 2), DfliC (lane 3), and untreated skin explants (lane 4), a PCR control for DNA contamination (lane 5) and the PCR product using
PAK genomic DNA (lane 6).
doi:10.1371/journal.pone.0016433.g002
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flagellin together with DOC, CHAPS or CTAB showed no visible
psoriasin expression as revealed by immunohistochemistry (Fig. 5).
Solely, analyses of skin that has been stimulated with TWEEN 20
along with flagellin resulted in a visible increase of psoriasin
expression, similar to that obtained for rhamnolipids and flagellin
(compare Fig. 5 and 3).
Rhamnolipid mediated induction of psoriasin in human
ex vivo skin is not restricted to flagellin
The previous results assume a rhamnolipid based shuttle system
across the stratum corneum. To investigate whether a rhamnolipid
mediated transport across this barrier is restricted to flagellin or
might also be achieved with other proteins, a combination of the
cytokines IL-17 and IL-22 was used instead of flagellin. IL-17 and
IL-22 are potent inducers of psoriasin and a combination of them
has been shown to be more effective in inducing psoriasin
secretion in keratinocytes than the two cytokines separately [27].
Immunohistochemical analyses of ex vivo skin biopsies, treated with
a mixture of IL-17 and IL-22, revealed no detectable psoriasin
expression within the epidermis (Fig. 6). In contrast, using this
mixture in combination with rhamnolipids, the suprabasal
epidermal layer showed distinct psoriasin expression (Fig. 6).
Rhamnolipids form vesicles and do not enhance
flagellin-induced psoriasin expression in vitro
Rhamnolipids resemble glycolipids and are able to form
micelles or vesicles (liposomes). Therefore vesicle formation and
the uptake of FITC (fluorescein isothiocyanate)-labeled flagellin
was investigated at pH 5, reflecting the physiological pH of skin.
As shown in Figure 7a, rhamnolipids form flagellin embedded
vesicles of different size.
Vesicles display potential carrier molecules and may enable a
transmembrane transport and a possible translocation of PAMPs
into the host cell. Therefore a possible impact of rhamnolipids on
flagellin- and IL17/IL-22-induced psoriasin secretion was inves-
tigated in cultured keratinocytes. Rhamnolipids were applied at
Figure 3. Rhamnolipids enable flagellin-induced psoriasin expression in human skin. Immunohistochemical analyses of psoriasin
expression (Vector red) in full-thickness ex vivo skin biopsies. Biopsies were incubated with purified P. aeruginosa flagellin (700 ng/ml) in the absence
and presence of rhamnolipids (37.5 mg/ml) in DMEM for 48 h. One representative experiment is shown (n=3–6). SC: stratum corneum; E: living
epidermis;D :dermis.
doi:10.1371/journal.pone.0016433.g003
Table 1. Rhamnolipid production of different motile P.
aeruginosa strains and clinical isolates.
P. aeruginosa isolate (source) Rhamnolipid concentration (mg/ml)
PAO1 336678
PAK 3866
PAKDfliC 2061
PA-O (skin) 56617
PA227 (blood) 63610
PA264 (skin) 538676
PA391 (CF-lung) 79561
PA1450 (skin) 702625
Rhamnolipids were isolated from 24 h cultures of different P.aeruginosa isolates
by chloroform extraction and quantified by the Methylene-blue method. The
rhamnolipid concentration is given as the mean 6 SD of three independent
experiments.
doi:10.1371/journal.pone.0016433.t001
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known to be cytotoxic for cultured keratinocytes [28]. Neither
flagellin- nor IL-17/IL-22-induced psoriasin expression was
significantly enhanced in the presence of rhamnolipids, as
determined by unpaired student’s t-test (Fig. 7b, c). As shown in
Figure 7b and c, rhamnolipids by their own raise neither the
psoriasin nor IL-8 release in human keratinocytes at the used
concentrations.
Discussion
P. aeruginosa occupies a diversity of ecological niches, last but not
least due the versatile and non-stringent metabolic requirements.
Thus it is not astonishing that P. aeruginosa is quite commonly
found on human skin [29,30]. While intact skin is rarely infected
with P. aeruginosa, impairment of the skin as burns, chronic
wounds, or surgery frequently result in severe infections outlining
the protective functions of the epidermal skin barrier.
This prompted us to examine the effects of P. aeruginosa and the
P. aeruginosa derived PAMP flagellin, respectively, when encoun-
tering the skin. Both, application of P. aeruginosa directly on skin as
well as separated from skin by transwells, resulted in an induction
of psoriasin in the living epidermis (Fig. 2a). Keeping in mind that
flagellin is the principal inducer of psoriasin expression in
keratinocytes in vitro [9] and that the flagellin deficient mutant
did not show any detectable psoriasin expression in ex vivo skin
(Fig. 2a), highlights the role of flagellin as major PAMP. However,
purified flagellin, applied to skin ex vivo, did not induce a response
of the innate immunity in form of a psoriasin expression in the
living epidermis at all (Fig. 3). This raised the question how P.
aeruginosa derived flagellin is delivered across the dead corneocytes
of the stratum corneum to responding host cells. The stratum corneum
confers impermeability towards most solutes and this constitutes a
well known problem in transdermal drug delivery that usually can
be bypassed by empirically determined compositions of detergents
and lipids or liposomes [31]. We speculate that P. aeruginosa
rhamnolipds as glycolipids act in a similar way. Rhamnolipids
display detergent like properties and were secreted by P. aeruginosa
in the used ex vivo skin model (Fig. 2c). Verifying this hypothesis,
flagellin applied in the presence of P. aeruginosa derived
rhamnolipids provoked a psoriasin expression in ex vivo skin
comparable to that from P. aeruginosa wildtype (compare Fig. 3 with
Fig. 2a). Rhamnolipids alone had no effect on the psoriasin
induction in the used skin model. Our findings support the
hypothesis that rhamnolipids act as a shuttle system for flagellin
transport across the stratum corneum. Although detergent properties
Figure 4. Electrospray-ionization-mass-spectrum of rhamnolipids isolated from the clinical isolate PA264. Analyses of the rhamnolipid
preparation were performed in the negative ionization mode. The ion at m/z 503 corresponds to the mono-rhamnolipid Rha-C10-C10 as revealed by
MS/MS analyses of m/z 503 displayed in the inset. The ion at m/z 649 corresponds to the dirhamnolipid Rha-Rha-C10-C10 as revealed by MS/MS
analyses of m/z 649 displayed in the inset. The corresponding and characteristic ions formed by collision-induced fragmentation are underlined.
doi:10.1371/journal.pone.0016433.g004
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be sufficient as indicated by the failure of most of the tested
detergents to facilitate the flagellin-induced psoriasin expression
(Fig. 5).In contrast to acetone (Fig. 5) or tape stripped skin barrier
disruption [27], the integrity of the stratum corneum was obviously
not disturbed by rhamnolipids, indicated by the absence of
psoriasin expression in rhamnolipid-treated skin. In accordance to
this no elevated transepidermal water loss, determined on a
standardized area of the forearms of healthy volunteers could be
detected (data not shown). This observation implicates a vesicle- or
micelle-based delivery system for the rhamnolipid mediated
flagellin transport across the stratum corneum that does not damage
Figure 5. Effects of acetone and different detergents on flagellin-induced psoriasin expression in human skin.F o r
immunohistochemical analyses of psoriasin expression (Vector red) in full-thickness ex vivo skin explants, biopsies were incubated with the
different surfactants (the anionic detergent DOC, the zwitterionic CHAPS, the cationic CTAB, and the nonionic TWEEN 20) in DMEM for 48 h in
presence and absence of P. aeruginosa flagellin. Surfactants were added above their CMC. The surfactant net charge is given in brackets. To disorder
the physical barrier, ex vivo skin was treated with acetone prior incubation with flagellin. One representative experiment out of three is displayed.
doi:10.1371/journal.pone.0016433.g005
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form polydisperse vesicles at pH levels around 5 [32], which is the
natural pH of the skin surface, and were able to encase FITC-
labeled flagellin (Fig. 7a). Ongoing investigation revealed that the
rhamnolipid-based shuttle system is not restricted to flagellin. Even
host derived factors as the cytokines IL-17 and IL-22 were shuttled
by the aid of rhamnolipids assuming that the rhamnolipid-based
delivery system could constitute a universal shuttle system
throughout the skin barrier. Connecting this universal shuttle
system with the excellent antimicrobial activity of rhamnolipids
against a wide range of bacteria and fungi [14,15], it can be
assumed that also factors from P. aeruginosa competitors or
commensals on skin might be delivered across the stratum corneum
finally resulting in activation of a specific host response. A recent
study by Abtin [33] gives reason to speculate that this system is not
restricted to P. aeruginosa. Here the authors demonstrated that E.coli
is also able to induce the TLR-5 mediated antimicrobial
heterodimer calprotectin on ex vivo skin explants.
Our experiments using the flagellin-deficient P. aeruginosa
mutant highlight the importance of flagellin as a key PAMP.
Extracellular recognition of flagellin by the host is generally
mediated by TLR-5 and finally lead to the induction of
proinflammatory mediators like IL-8 and AMPs [9], while
cytosolic flagellin is detected through the NOD-like receptor Ipaf,
which leads to the activation of the inflammasom [34]. In addition
to the delivery of flagellin into the cytosol via specific virulence
factor transport systems (the type III and type IV secretion system),
a long distance delivery system for bacterial virulence factors via
outer membrane vesicles directly into the host cell cytoplasm was
recently proposed by Bomberger and colleagues [35]. Verifiyng
that rhamnolipid vesicle may potentially be able to fuse with the
cell membrane of the host and release its contents into the
cytoplasm, in vitro co-stimulations of keratinocytes with rhamno-
lipid and flagellin were performed but did not significantly
enhance the induction of IL-8 and psoriasin (Fig. 7b) under the
used experimental conditions. This result suggest that the
induction of IL-8 and psoriasin by flagellin seems unlikely to be
caused by intracellular recognition.
Researchers generally work with laboratory strains under
controlled conditions but this might not reflect the potential of
clinical isolates of P. aeruginosa. Previous reports have shown that
only a minority of tested clinical strains failed to produce
rhamnolipids [36], even though rhamnolipids cause the release
of PAMPs [20,22]. The herein investigated clinical isolates did not
diminish the production or change the composition of secreted
rhamnolipids (Table 1; Fig. 4) although rhamnolipids seem to be
an Achilles’ heel for P. aeruginosa during growth on the healthy skin
surface.
In conclusion, our data suggest that rhamnolipids were
produced during initial settlement of P. aeruginosa at the skin
surface, maybe to eliminate competitors, supporting the biodeg-
radation of the hydrophobic stratum corneum, or to establish
microcolonies [12]. Consequently, the rhamnolipid secretion
caused the release of the main psoriasin-stimulus flagellin [22].
Thereafter flagellin, likely encased by rhamnolipids, was shuttled
to the living epidermis via the stratum corneum. Consecutively,
flagellin causes an induction of an antimicrobial defense response
in the uppermost epidermal layers. This early and efficient
keratinocyte defense reaction during a most vulnerable phase of
the pathogen might explain why P. aeruginosa is only a transient
constituent of human’s healthy skin (Fig. 8).
Materials and Methods
Ethics Statement
All experiments were performed according to the Declaration of
Helsinki protocols and were approved by the ethics committees of
the Medical Faculty of the Christians-Albrechts-University/
University Hospital Schleswig-Holstein, Kiel, Germany (AZ
104/06). Skin explants for ex vivo experiments derived from
patients undergoing plastic surgery after written informed consent.
Bacterial growth conditions and strains
P. aeruginosa strains were maintained as glycerol stocks at 280uC
and grown on trypticase soy agar or in trypticase soy broth (TSB)
overnight at 37uC under agitation (200 rpm). For rhamnolipid
production P. aeruginosa was grown overnight at 37uC with
agitation (200 rpm) in 1% peptone 1% glucose medium. For
swimming assays strains were grown overnight on TSB agar plates
at 37uC. Individual colonies were then stabbed onto swimming
plates (TSB, 0.3% agar (w/v)) with a sterile toothpick and
incubated at 22uC. Swimming motility was determined by
measuring the diameter of the turbid zone around the inoculation
site. Strain PAK and its DfliC mutant [37] were obtained from Dr.
R. Ramphal (Gainesville, Florida). The laboratory strain PAO1
originate from the Holloway collection. Strains PA227; PA264;
PA391,P A1450 and PA-O [38] were obtained from patients at the
University Hospital Schleswig-Holstein, Kiel, Germany.
Cell Culture
Foreskin derived primary keratinocytes were isolated from
neonatal foreskin as described [39] and cultured in EpiLife
Figure 6. IL-17/IL-22 induced psoriasin expression in ex vivo skin is mediated by rhamnolipids. For immunohistochemical analyses of
psoriasin expression (Vector red) in full-thickness ex vivo skin explants, biopsies were incubated with a mixture of IL-17 (50 ng/ml) and IL-22 (50 ng/
ml) in DMEM for 24 h in the absence or presence of P. aeruginosa rhamnolipids (37.5 mg/ml). A representative experiment is shown (n=3).
doi:10.1371/journal.pone.0016433.g006
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PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16433Figure 7. Rhamnolipids form vesicles and do not alter the potency of flagellin and IL17/IL-22 in cultured keratinocytes. A:
Representative photomicrograph showing FITC-labeled flagellin embedded in rhamnolipid (RL) vesicle (indicated by arrowhead). On the left hand the
control without rhamnolipid (4006magnification) B: Psoriasin- and IL-8-secretion was measured by ELISA in the supernatants of cultured primary
keratinocytes after incubation with rhamnolipids (0.05 mg/ml), a mixture of the cytokines IL-17 and IL-22 (both 50 ng/ml), as well as a combination of
rhamnolipids and cytokines for 24 h. C: Secreted psoriasin and IL-8 was determined by ELISA in supernatants of primary keratinocytes, stimulated
with rhamnolipids (0.05 mg/ml) and/or flagellin (100 ng/ml) for 24 h. The release is given as the mean 6 SD (n=3). The addition of rhamnolipid
during stimulation did not alter the potency of the used stimuli (n.s.: not significant) as determined by unpaired student’s t-test.
doi:10.1371/journal.pone.0016433.g007
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2 flasks (BD
Biosciences) in a humidified atmosphere with 5% CO2. For
stimulation experiments cells were seeded in 12-well tissue culture
plates (BD Biosciences) and used at 80–90% confluence. Cells
were stimulated with purified flagellin of P. aeruginosa PAK, IL-17,
and IL-22 (PeproTech) at indicated concentrations and time
points.
RNA isolation, cDNA synthesis, and qualitative rhlA PCR
At the end of the stimulation experiment skin samples were
minced in liquid nitrogen and RNA was isolated using the
NucleoSpin RNA II kit (Macherey&Nagel), according to the
supplier’s protocol. RNA quality and quantity were determined by
photometry. To check for DNA contamination, RNA samples
were analyzed by PCR using primers for rhlA. Subsequently, 1 mg
of total RNA was reverse transcribed into cDNA using random
hexamer primers and 50 units Superscript II (Invitrogen)
according to the manufacturer’s protocol. Qualitative rhlA PCR
was performed with the rhlA forward primer 59 CGA AAG TCT
GTT GGT ATC GG 39, rhlA reverse primer 59 CGT CCT TGG
TGA TCA ACC C 39 and cDNA corresponding to 20 ng RNA as
template in a 25 ml reaction.
ELISA
The psoriasin ELISA was performed as described previously
[8]. IL-8 was detected in keratinocyte culture supernatants using a
commercially available IL-8 ELISA (R&D Systems).
Rhamnolipid purification and quantification
Bacteria grown to an OD600nm of 2-2.5 were pelleted by
centrifugation and the supernatant was sterile filtrated and
acidified with HCl to pH 3. Rhamnolipids were extracted twice
by addition of two volumes ethylacetate. The pooled organic
fractions were vacuum-dried and the lyophilizated sample was
dissolved in distilled water and analyzed by ESI-MS. Quantifica-
tion of rhamnolipids in the culture broth were determined by
complexation of rhamnolipids and Methylene-blue as described
[40].
Rhamnolipid vesicle
Rhamnolipids were dissolved with FITC-labeled flagellin in
chloroform-methanol (2:1 v/v) The solvent was evaporated
(Heidolph rotary evaporator) and sodium phosphate buffer
(10 mM, pH 5) was added to reach the final concentration of
37.5 mg/ml rhamnolipids. The content of the flask was stirred
vigorously at room temperature. The incorporation of the FITC-
labeled flagellin into rhamnolipid vesicle was observed by analyses
with a microscope (4006magnification). FITC was excited using a
100W HBO mercury lamp in conjunction with a FITC filter
(OLYMPUS).
Mass spectrometry (MS)
For mass analyses purified rhamnolipid preparations were
dissolved in 50% acetonitrile-water and characterized by electro-
spray-ionization-mass-spectrometry (ESI-MS) in the negative
ionization modus. The analyses were performed with a Quad-
rupol-Time-of-Flight-Hybrid-Mass spectrometer (Q-TOF
TMII,
Waters Micromass, Milford, Massachusetts) equipped with an
orthogonal electrospray source (Z-spray). For MS/MS analyses
nanoelectrospray ionization [41] was used and were carried out
after fitting the Q-Tof
TMII mass spectrometer with a nano Z-spray
source.
SDS-PAGE and Western Blot
The bacterial culture supernatants were boiled in 46 loading-
buffer (4% SDS, 60% Glycerol, 0.3 M Tris, 0.01% Coomassie
Brillant Blue G-250). Tricine-SDS-PAGE was then performed in
4% stacking and 10% separation gels as described by Scha ¨gger
[42].
Flagellin was transferred to nitrocellulose membranes (SIGMA)
and blocked with 5% (w/v) dried skim milk in 0.05% TWEEN 20
in PBS. Immunoblotting was performed with polyclonal anti-
flagellin kindly provided by Dr. R. Ramphal.
Purification of flagellin
Flagellin was purified from Pseudomonas strain PAK grown
overnight in TSB. Bacteria were pelleted by centrifugation and
Figure 8. Proposed model for rhamnolipid mediated delivery of flagellin across the stratum corneum. Rhamnolipids released from P.
aeruginosa form micelles or vesicles and shed flagellin. Rhamnolipid embedded flagellin penetrates the human stratum corneum and is subsequently
released into the living epidermal cell layers. Here flagellin activates keratinocytes (red) and induces the production and release of AMPs, which in
turn kill P. aeruginosa.
doi:10.1371/journal.pone.0016433.g008
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removed by heat treatment at 65uC for 10 min, bacteria were
pelleted again by centrifugation and supernatants were supple-
mented with 0.1 M MgCl2 (final). Solutions were allowed to
incubate over night at 4uC. Precipitated flagellin was then
harvested by centrifugation and dissolved in 20 mM TRIS-Cl
pH 8. Flagellin-enriched samples were loaded onto Mini Q PC
3.2/3 anion-exchange column (GE Healthcare, Munich, Ger-
many) on an ETTAN
TM HPLC system and eluted with linear
gradient of 1 M NaCl. Flagella eluted at 0.2 M NaCl as monitored
by A280nm. The presence of flagellin was confirmed by a
characteristic 49 kDa band in silver-stained polyacrylamide gels
or immunoblotting using anti flagellin. FITC labeling of flagellin
was performed as described by the manufacturer (SIGMA).
Separation of FITC labeled flagellin from unbound FITC was
performed by using 30 kDa cutoff ultrafiltration devices (Milli-
pore).
Ex vivo stimulation of human skin
Skin explants for ex vivo experiments derived from plastic surgery
were kindly provided by C. Preissner (Vital-Aesthetic–Clinic Kiel,
Germany). Fresh tissue was transferred into PBS and immediately
used for experiments. Subcutaneous fat was removed mechanically
and skin explants were washed in PBS. Punch biopsies (6 mm
diameter) were taken, placed into the wells of 96 well tissue culture
plates (BD Biosciences) filled with 100 ml DMEM medium (Cell
Concepts) and finally stimulated with flagellin, IL-17/IL22 or a
combination of the stimuli and surfactant (rhamnolipids: JBR515
Jeneil Biosurfactant; DOC; CHAPS; CTAB; TWEEN 20, (all
SIGMA) at concentrations of 37.5 mg/ml, 3 mg/ml, 4 mg/ml,
1 mg/ml, and 0.1 mg/ml, respectively), and appropriate controls.
For disorder of the stratum corneum, skin explants were wiped with
acetone-soaked swabs before punch biopsies were taken. The
explants were incubated for 48 h at 37uC in a humidified
atmosphere with 5% CO2. Using living bacteria, bacteria were
separated from punch biopsies by transwells (NUNC tissue culture
inserts, 0.2 mm pore size) and 10000 CFU of PAK or DfliC were
applied. Untreated skin served as control. Incubation was
performed for 24 h at 37uC in a humidified atmosphere with
5% CO2. For exposure of PAK and DfliC directly on skin, explants
of 1 cm
2 were placed on DMEM-drained dressing material in 12
well tissue culture wells, and were exposed to living bacteria for
24 h at 37uC in a humidified atmosphere with 5% CO2. After
incubation, punch biopsies were taken and fixed in 4% formalin
over night and embedded in paraffin.
Immunohistochemical analyses
To investigate psoriasin protein expression in skin explants,
paraffin sections were analyzed by immunohistochemistry as
described previously [8]. To test the specificity of the used
antibody, positive staining derived from rhamnolipid and flagellin
co-stimulated skin explants were incubated with the psoriasin
monoclonal antibody preabsorbed with 1 mg of skin derived
psoriasin (data not shown). Intensity of psoriasin immunoreactivity
in the epidermal layer and the corresponding controls were
optically evaluated and scored in arbitrary units (Fig. S1).
Supporting Information
Figure S1 Scoring of the psoriasin expression in immunhisto-
chemistry analyses was accessed by visual judgment of the
processed paraffin sections and scored in arbitrary units. (RL:
rhamnolipid)
(TIF)
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